Reneuron Group Plc. revenue breakdown overview

Reneuron Group Plc. revenue for the last year amounted to 653.65 k USD, the most of which — 653.65 k USD — came from its highest performing source at the moment, Cell-based Therapies, the year earlier bringing 529.26 k USD. The greatest contribution to the revenue figure was made by United Kingdom, United States, China and South East Asia — last year it brought Reneuron Group Plc. 485.92 k USD, and the year before that — 372.98 k USD.